This is a working overview of reversed-phase HPLC, written for readers who want more than a one-paragraph summary but less than a textbook.
Reviewed 2026-06-19. Anything still debated is marked as such rather than presented as settled.
Tirzepatide is a synthetic peptide of 39 amino acids engineered from the native glucose-dependent insulinotropic polypeptide sequence. Its structure incorporates several non-natural residues and a C-terminal segment derived from glucagon-like peptide-1, together with a C20 fatty diacid moiety attached through a linker. The lipophilic side chain promotes binding to serum albumin, which slows renal clearance after administration. The compound is classified as a dual incretin receptor agonist and is supplied as a lyophilized powder for reconstitution or as a preformulated solution, depending on the presentation.
The peptide activates two G protein-coupled receptors, GIPR and GLP-1R. Binding triggers adenylyl cyclase activity and raises intracellular cyclic AMP in pancreatic beta cells, which potentiates insulin release when glucose is elevated. Signaling in the central nervous system is associated with reduced appetite and lower energy intake, while effects on gastric emptying and glucagon secretion are also reported. Because activity at both receptors is retained, the pharmacological profile is often described as incretin-based rather than selective for a single receptor.
After subcutaneous injection, absorption is gradual, and peak plasma levels are generally reached within one to three days. Albumin binding extends the apparent half-life to roughly five days, which supports a weekly administration schedule. Metabolism proceeds mainly through proteolytic cleavage of the peptide backbone and beta-oxidation of the fatty acid chain, rather than through cytochrome P450 pathways. Eliminated fragments are largely recycled through general protein turnover, and excretion of intact drug in urine is minimal. These properties distinguish the molecule from short-acting incretin mimetics.
Routine characterization relies on reversed-phase high-performance liquid chromatography, often coupled to mass spectrometry, to confirm identity and estimate purity. Peptide mapping after enzymatic digestion verifies the amino acid sequence and locates appended groups such as the fatty acid chain. Size-exclusion chromatography detects aggregates and fragments, while ion-exchange chromatography resolves charge variants. Circular dichroism and nuclear magnetic resonance supply secondary and higher-order structural information in research settings. No single technique covers every attribute, so laboratories combine orthogonal methods and compare outcomes against a reference standard where one exists.
Purified material is typically handled as a lyophilized powder kept at or below minus twenty degrees Celsius, shielded from light and moisture. In that state the solid remains stable for extended periods, although repeated freeze-thaw cycling can encourage aggregation. Once dissolved, aqueous solutions are less durable and are generally held cold and used within a brief window. Buffer composition, pH and ionic strength all influence degradation rates, and mildly acidic to neutral conditions are commonly examined. Actual shelf life depends on formulation, concentration and container, so stability limits are established experimentally rather than assumed.
Verification of research-grade material involves checking purity, sequence and counter-ion content against a certificate of analysis. Reported purity figures usually reflect chromatographic area percentage and do not by themselves establish biological activity. Independent laboratories may repeat mass confirmation and peptide mapping to detect substitutions or truncations. Open questions concern how residual solvents, trace metals and subtle conformational variants affect measured behavior, and how consistently different suppliers define their specifications. Documentation of analytical methods matters as much as the headline purity number when results are compared across studies.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C225H348N48O68 | Approximate composition of the free peptide |
| Molecular weight | Approximately 4813 Da | Calculated for the free base |
| Structural class | Synthetic linear peptide | 39 residues with modified backbone |
| Solubility | Soluble in water and polar solvents | Behavior of the lyophilized solid |
| Typical storage temperature | -20 degrees Celsius or below | Solid form, protected from light |
The compound first appeared in the scientific literature as an investigational agent for type 2 diabetes. Clinical development proceeded through phase 1, phase 2, and phase 3 programs that measured glycemic control as a primary endpoint while recording body weight as a secondary outcome. Regulatory approval in the United States followed in 2022 for glycemic control, and a separate indication for chronic weight management was added later. Subsequent trials have examined cardiovascular outcomes in adults with elevated cardiovascular risk. Debates continue over how much of the observed effect derives from each receptor arm.
Structural work on the molecule centers on a C20 fatty diacid moiety attached through a linker to the peptide backbone. This side chain promotes reversible binding to serum albumin, which slows renal clearance and supports a prolonged action profile. The peptide backbone incorporates aminoisobutyric acid substitutions that limit recognition by digestive enzymes. Together these modifications produce a molecule that is stable enough for subcutaneous delivery but still dependent on careful manufacturing control. Analytical characterization of the active pharmaceutical ingredient typically follows the conventions used for other synthetic peptides.
Bulk peptide material is normally characterised by reversed-phase high-performance liquid chromatography, which separates the target sequence from truncation products and other closely related impurities. Ultraviolet detection near 214 nanometres is common because the peptide backbone absorbs in that region. Mass spectrometry, usually electrospray ionisation coupled to a mass analyser, is used to confirm the molecular mass. Because the molecule carries a lipophilic side chain, gradient methods often need a relatively high organic modifier fraction to elute it within a practical retention window.
Like most synthetic peptides of this size, the material is commonly supplied as a lyophilised powder that appears white to off-white. It dissolves in aqueous buffers and in mixtures of water with a small proportion of organic solvent, though the fatty acid portion reduces solubility in pure water relative to short peptides. Hygroscopic behaviour is reported for many peptide powders, so weighing is usually performed quickly and under controlled humidity. Working solutions are typically prepared fresh and kept cold.
Long-term storage of lyophilised peptide powder is generally at minus twenty degrees Celsius or colder, with desiccant and protection from light. Short-term storage at two to eight degrees Celsius is common during active use. In solution, stability depends strongly on pH, concentration, and the presence of preservatives, and hydrolysis or aggregation can develop over weeks. Published stability data specific to this molecule are limited, so recommended conditions for research material are usually extrapolated from general peptide handling practice rather than from a dedicated study.
TVLine reported in late April that a new gladiator would be added to Olivia Pope & Associates, and the person would be a guest star. It was also announced on July 7, 2015, that Cornelius Smith Jr., who had a guest role in season four playing activist Marcus Walker, will be returning as a series regular for the fifth season, but will not appear until later in the fall. On August 24, 2015, it was announced that actress Mia Maestro would be recurring during the fifth season, but the specifics of her role were not revealed. Julie Claire was announced on September 1, 2015, to have joined the cast in a guest role. It was announced on February 4, 2016, that Ricardo Chavira would join the show in a recurring role, and would first appear in the eleventh episode. Annabeth Gish was announced on February 8, 2016, to have been cast in a recurring role. The Hollywood Reporter announced on February 18, 2016, that Joe Morton who plays Rowan "Eli" Pope had been promoted to a series regular, and was credited as a regular cast member for the first time in the twelfth episode.
=== Dextran microsphere applications === Dextran-based microspheres can encapsulate a variety of drugs and provide therapeutic delivery in the treatment of diseases such as cancer, colonic diseases, bone diseases, and cardiovascular diseases.
===== Daniela Carneiro ===== In the same month Minister of Tourism Daniela Carneiro came under scrutiny for her association with individuals believed to command militias in Rio de Janeiro. Carneiro, a member of the Brazil Union party, had been included by the Lula government in the Ministry of Tourism in order to increase its alliance with parties of different political positions. According to a report by Veja, Daniela, the most voted federal deputy in Rio de Janeiro in 2022, was introduced to Lula by Washington Quaquá, coordinator of Lula's campaign in Rio, and was also chosen for other characteristics considered important for the PT: being a woman and evangelical. After the appointment of Daniela, previously known as Daniela do Waguinho, press outlets began publishing a series of reports showing involvement of Carneiro's political group with militias in the Baixada Fluminense, which had also previously shown involvement and links with other politicians from right-wing parties. On 3 January, g1 published a 2018 photo of Daniela alongside Juracy Alves Prudêncio, better known as Jura, a former military police sergeant identified as the leader of a militia responsible for killings in the Baixada Fluminense. Juracy appears in videos working as a campaign worker for her. He was sentenced to 26 years in prison for murder, moved to the semi-open prison regime in 2017, and went to work at the city hall of Belford Roxo, where the mayor was Wagner dos Santos Carneiro, known as Waguinho, Daniela's husband.
Sources: en.wikipedia.org
=== US NRC general license === US Nuclear Regulatory Commission regulations at 10 CFR 40.25 establish a general license for the use of depleted uranium contained in industrial products or devices for mass-volume applications. This general license allows anyone to possess or use depleted uranium for authorized purposes. Generally, a registration form is required, along with a commitment to not abandon the material. Agreement states may have similar, or more stringent, regulations.
Plutonium-241 (241Pu, Pu-241) is an isotope of plutonium formed when plutonium-240 captures a neutron. Like some other plutonium isotopes (especially 239Pu), 241Pu is fissile, with a neutron absorption cross section about one-third greater than that of 239Pu, and a similar probability of fissioning on neutron absorption, around 73%. In the non-fission case, neutron capture produces plutonium-242. In general, isotopes with an odd number of neutrons are both more likely to absorb a neutron and more likely to undergo fission on neutron absorption than isotopes with an even number of neutrons.
Southern Rhodesia, then a self-governing colony of the United Kingdom that was located in the now-independent Zimbabwe, entered World War II along with Britain shortly after the invasion of Poland in 1939. By the war's end, 26,121 Southern Rhodesians of all races had served in the armed forces, 8,390 of them overseas, operating in the European theatre, the Mediterranean and Middle East theatre, East Africa, Burma and elsewhere. The territory's most important contribution to the war is commonly held to be its contribution to the Empire Air Training Scheme (EATS), under which 8,235 British, Commonwealth and Allied airmen were trained in Southern Rhodesian flying schools. The colony's operational casualties numbered 916 killed and 483 wounded of all races. Southern Rhodesia had no diplomatic powers, but largely oversaw its own contributions of manpower and materiel to the war effort, being responsible for its own defence. Rhodesian officers and soldiers were distributed in small groups throughout the British and South African forces in an attempt to prevent high losses. Most of the colony's men served in Britain, East Africa and the Mediterranean, particularly at first; a more broad dispersal occurred from late 1942. Rhodesian servicemen in operational areas were mostly from the country's white minority, with the Rhodesian African Rifles—made up of black troops and white officers—providing the main exception in Burma from late 1944. Other non-white soldiers and white servicewomen served in East Africa and on the home front within Southern Rhodesia.
According to some reports and textbooks, the number of adipocytes can increase in childhood and adolescence, though the amount is usually constant in adults. Individuals who become obese as adults, rather than as adolescents, have no more adipocytes than they had before.
Sources: en.wikipedia.org
It is a synthetic linear peptide that acts as a dual agonist at the GIP and GLP-1 receptors. It combines a modified incretin backbone with a fatty diacid side chain that extends its circulation time. It is not a small-molecule drug and is not orally absorbed in its native form.
Single-receptor agents act predominantly at GLP-1R. Tirzepatide retains activity at GIPR, which is expressed in pancreatic islets, adipose tissue, and the central nervous system. The contribution of each receptor to the overall response is still an area of active study, and the relative weight of GIPR signaling in humans is not fully settled.
The fatty diacid moiety binds serum albumin, which reduces renal filtration of the active peptide. Additional resistance to enzymatic breakdown comes from non-natural residues in the backbone. Together these features produce an apparent half-life of about five days and permit weekly dosing intervals.
Liquid chromatography combined with mass spectrometry is the most common approach. Digestion followed by peptide mapping verifies the sequence and modification sites. Results are judged against a reference standard or a theoretically calculated mass.